Registry-listed formulations

apimostinel · chembl:CHEMBL3989872

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • Apimostinel Infusion, IntravenousRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(50%)
Results Posted
0%(0 trials)

Phase Distribution

Phase 2
1
50%
Phase 1
1
50%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
Phase 2Efficacy & side effects
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Completed(1)

Detailed Status

Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (50.0%)
Phase 21 (50.0%)

Trials by Status

completed150%
recruiting150%

Recent Activity

1 active trials
Showing 2 of 2
recruitingphase_2

Apimostinel + Automated Neurocognitive Training for Depression

NCT06400121
completedphase_1

Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers

NCT05597241

Clinical Trials (2)

Showing 2 of 2 trials
NCT06400121Phase 2

Apimostinel + Automated Neurocognitive Training for Depression

Recruiting
NCT05597241Phase 1

Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers

Completed

All 2 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Protein
Total Trials
2

External References

ChEMBL
CHEMBL3989872

Names & Codes

Research Codes

NRX1074